Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly MRNA is now a well known name in the production of COVID-19 vaccine and is only one of three that have received approval in the US. Purchase agreements amounted to $18 billion, allowing cash flow reserves of the company to balloon. The company is now working on a single-dose product that does not require extreme refrigeration. The pullback in the share price, and a forward PE of 9x earnings, offers a good entry level here. We would buy this with a stop loss at $90, looking to achieve $175 -- upside potential of 29%. Yield 0% (Analysts’ price target is $174.25)
Show full opinionHide full opinion
Moderna (MRNA-Q)
April 8, 2021
Stockchase Research Editor: Michael O'Reilly MRNA is now a well known name in the production of COVID-19 vaccine and is only one of three that have received approval in the US. Purchase agreements amounted to $18 billion, allowing cash flow reserves of the company to balloon. The company is now working on a single-dose product that does not require extreme refrigeration. The pullback in the share price, and a forward PE of 9x earnings, offers a good entry level here. We would buy this with a stop loss at $90, looking to achieve $175 -- upside potential of 29%. Yield 0% (Analysts’ price target is $174.25)
Stockchase Research
Price
$133.290
Owned
_N/A
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly The semiconductor space saw global chip sales up over 14% last year and there is now a global shortage of supply. UMC is a Taiwan based chip producer and recently released sales were up 14%. It has beat earnings estimates in each of the past three reporting cycles. It trades at 31x earnings, cheap compared to its peers at 68x. It also pays a small dividend. We would buy this with a stop loss at $7, looking achieve $11.50 -- upside potential over 20%. Yield 1.56% (Analysts’ price target is $11.55)
Show full opinionHide full opinion
Stockchase Research Editor: Michael O'Reilly The semiconductor space saw global chip sales up over 14% last year and there is now a global shortage of supply. UMC is a Taiwan based chip producer and recently released sales were up 14%. It has beat earnings estimates in each of the past three reporting cycles. It trades at 31x earnings, cheap compared to its peers at 68x. It also pays a small dividend. We would buy this with a stop loss at $7, looking achieve $11.50 -- upside potential over 20%. Yield 1.56% (Analysts’ price target is $11.55)
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly VIAC is a media monster. Recently reported earnings beat analyst expectations and showed streaming sales were up over 70% and operating cash flow was $2.2 billion and cash reserves are now over $3 billion. Recent stock price volatility has been associated to a forced liquidation by hedge fund that impacted several other unrelated entities. This creates a good entry point as it is now trading at under 20x earnings, compared to peers at over 45x. It pays a modest dividend, backed by a payout ratio under 25% of cash flow. We would buy this with a stop loss at $25, looking to achieve $57.50 -- upside potential over 32%. Yield 2.19% (Analysts’ price target is $57.48)
Show full opinionHide full opinion
ViacomCBS (VIAC-Q)
April 8, 2021
Stockchase Research Editor: Michael O'Reilly VIAC is a media monster. Recently reported earnings beat analyst expectations and showed streaming sales were up over 70% and operating cash flow was $2.2 billion and cash reserves are now over $3 billion. Recent stock price volatility has been associated to a forced liquidation by hedge fund that impacted several other unrelated entities. This creates a good entry point as it is now trading at under 20x earnings, compared to peers at over 45x. It pays a modest dividend, backed by a payout ratio under 25% of cash flow. We would buy this with a stop loss at $25, looking to achieve $57.50 -- upside potential over 32%. Yield 2.19% (Analysts’ price target is $57.48)
DON'T BUY
DON'T BUY
April 8, 2021
Tracks investment grade corporates in the US. Expensive right now. The spread is so narrow, it's hard to get excited. The bond market is having a hard time finding value. Strongly avoid right now.
Show full opinionHide full opinion
Tracks investment grade corporates in the US. Expensive right now. The spread is so narrow, it's hard to get excited. The bond market is having a hard time finding value. Strongly avoid right now.
Paul Gardner, CFA
Price
$24.870
Owned
Unknown
DON'T BUY
DON'T BUY
April 8, 2021

He loves Loblaw, owned by WN. Even with the bakery sale, it will still trade at a discount. Nothing wrong with WN, but he'd rather own Loblaw, which makes up about 60% of WN's value.

Show full opinionHide full opinion

He loves Loblaw, owned by WN. Even with the bakery sale, it will still trade at a discount. Nothing wrong with WN, but he'd rather own Loblaw, which makes up about 60% of WN's value.

BUY
BUY
April 8, 2021
With rising rates, bonds are not ideal. It comes down to risk/return. You might not get a great rate of return, but you preserve capital. If the stock market trades off quickly, the bond market will trade higher. He'd hold his nose and realize that everyone needs a bit of bonds to stabilize their life.
Show full opinionHide full opinion
With rising rates, bonds are not ideal. It comes down to risk/return. You might not get a great rate of return, but you preserve capital. If the stock market trades off quickly, the bond market will trade higher. He'd hold his nose and realize that everyone needs a bit of bonds to stabilize their life.
Paul Gardner, CFA
Price
$15.810
Owned
Unknown
HOLD
HOLD
April 8, 2021
Heavily into retail, so has had a difficult time. Trades at a significant discount to NAV, and it's finally under-distributing, which is safer. Hold it, and hope for the recovery. Expects numbers to improve. Projects are coming online. The worst is behind them.
Show full opinionHide full opinion
Heavily into retail, so has had a difficult time. Trades at a significant discount to NAV, and it's finally under-distributing, which is safer. Hold it, and hope for the recovery. Expects numbers to improve. Projects are coming online. The worst is behind them.